Myocarditis associated with COVID-19 vaccination
A Buoninfante, A Andeweg, G Genov, M Cavaleri - npj Vaccines, 2024 - nature.com
Following the start of the COVID-19 vaccination campaign, the adverse events of myocarditis
and pericarditis were linked mainly to mRNA COVID-19 vaccines by the regulatory …
and pericarditis were linked mainly to mRNA COVID-19 vaccines by the regulatory …
Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine–associated myocarditis
Rare immune-mediated cardiac tissue inflammation can occur after vaccination, including
after SARS-CoV-2 mRNA vaccines. However, the underlying immune cellular and molecular …
after SARS-CoV-2 mRNA vaccines. However, the underlying immune cellular and molecular …
Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19
Autoantibodies have been shown to be implied in COVID-19 but the emerging autoantibody
repertoire remains largely unexplored. We investigated the new-onset autoantibody …
repertoire remains largely unexplored. We investigated the new-onset autoantibody …
The tumor-driven antibody-mediated immune response in cancer
P Paparoditis, Z Shulman - Current Opinion in Immunology, 2024 - Elsevier
Immune cells in the tumor microenvironment play a crucial role in cancer prognosis and
response to immunotherapy. Recent studies highlight the significance of tumor-infiltrating B …
response to immunotherapy. Recent studies highlight the significance of tumor-infiltrating B …
[HTML][HTML] Vaccination after develo** long COVID: Impact on clinical presentation, viral persistence, and immune responses
M Nayyerabadi, L Fourcade, SA Joshi… - International Journal of …, 2023 - Elsevier
Background Vaccination protects against severe COVID-19 manifestations. For those with
post-COVID-19 conditions (PCC) or long COVID, the impact of COVID-19 vaccination on the …
post-COVID-19 conditions (PCC) or long COVID, the impact of COVID-19 vaccination on the …
Elevated BMI reduces the humoral response to SARS‐CoV‐2 infection
Objective Class III obesity (body mass index [BMI]≥ 40 kg m− 2) significantly impairs the
immune response to SARS‐CoV‐2 vaccination. However, the effect of an elevated BMI (≥ …
immune response to SARS‐CoV‐2 vaccination. However, the effect of an elevated BMI (≥ …
[HTML][HTML] SARS-CoV-2 mRNA vaccines do not worsen autoimmunity in patients with autoimmune liver diseases
T Kälin, K Passarin, M Filipowic-Sinnreich… - Journal of …, 2024 - Elsevier
Introduction and aims mRNA vaccines against Severe Acute Respiratory Coronavirus 2
(SARS-CoV-2) infection have been associated with immune-related adverse reactions. We …
(SARS-CoV-2) infection have been associated with immune-related adverse reactions. We …
Autoantibodies against angiotensin‐converting enzyme 2 (ACE2) after COVID‐19 infection or vaccination
JYH Tsoi, J Cai, J Situ, WJ Lam… - Journal of Medical …, 2023 - Wiley Online Library
Autoantibodies against angiotensin‐converting enzyme 2 (ACE2) are frequently reported in
patients during coronavirus disease 2019 (COVID‐19) with evidence for a pathogenic role in …
patients during coronavirus disease 2019 (COVID‐19) with evidence for a pathogenic role in …
Clinical outcomes in hospitalized plasma and platelet transfusion recipients prior to and following widespread blood donor SARS‐CoV‐2 infection and vaccination
Background The safety of transfusion of SARS‐CoV‐2 antibodies in high plasma volume
blood components to recipients without COVID‐19 is not established. We assessed whether …
blood components to recipients without COVID‐19 is not established. We assessed whether …
[HTML][HTML] Impact of COVID-19 vaccination on symptoms and immune phenotypes in vaccine-naïve individuals with Long COVID
Background: Long COVID contributes to the global burden of disease. Proposed root cause
hypotheses include the persistence of SARS-CoV-2 viral reservoir, autoimmunity, and …
hypotheses include the persistence of SARS-CoV-2 viral reservoir, autoimmunity, and …